<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2025.1609421</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Personalized diagnosis of radiation pneumonitis in breast cancer patients based on radiomics</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wen</surname>
<given-names>Xiaobo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1612799/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhao</surname>
<given-names>Yutao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Dong</surname>
<given-names>Wen</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Congbo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Jinzhi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2884671/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiu</surname>
<given-names>Yutao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gao</surname>
<given-names>Chang&#x2019;e</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2954049/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Ming</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Pharmacy, Qingdao University</institution>, <addr-line>Qingdao</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Radiotherapy, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University</institution>, <addr-line>Kunming, Yunnan</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Cancer Institute of The Affiliated Hospital of Qingdao University and Qingdao Cancer Institute</institution>, <addr-line>Qingdao</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Medical Oncology, The First Affiliated Hospital of Kunming Medical University</institution>, <addr-line>Kunming</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Han Wang, Shanghai Jiao Tong University School Medicine, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Qiang Li, Ningbo University, China</p>
<p>Meng Wang, Liaoning Technical University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Ming Zhang, <email xlink:href="mailto:zhangming1@kmmu.edu.cn">zhangming1@kmmu.edu.cn</email>; Chang&#x2019;e Gao, <email xlink:href="mailto:gaochange@kmmu.edu.cn">gaochange@kmmu.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="ecorrected">
<day>26</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1609421</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Wen, Zhao, Dong, Yang, Li, Sun, Xiu, Gao and Zhang</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wen, Zhao, Dong, Yang, Li, Sun, Xiu, Gao and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>This study aimed to identify CT&#x2010;based radiomic alterations associated with radiation pneumonitis (RP) and to evaluate the feasibility of machine learning classifiers for personalized RP diagnosis in breast cancer patients using these radiomic signatures.</p>
</sec>
<sec>
<title>Methods</title>
<p>A total of 146 planning CT scans (pre- and post-radiotherapy) from 73 breast cancer patients with confirmed RP were retrospectively analyzed. The entire lung was delineated as the region of interest (ROI), and 1,834 radiomic features were extracted using PyRadiomics. Feature selection was performed sequentially using the Mann&#x2013;Whitney U-test (p &lt; 0.05), Spearman&#x2019;s rank correlation (|&#x3c1;| &lt; 0.9), and least absolute shrinkage and selection operator (LASSO). Eight classifiers [logistic regression (LR), support vector machine (SVM), K-nearest neighbor (KNN), random forest (RF), Extra Tree (ET), XGBoost, LightGBM, and multilayer perceptron (MLP)] were trained and evaluated using accuracy, area under the receiver operating characteristic curve (AUC) with 95% confidence intervals, sensitivity, and specificity.</p>
</sec>
<sec>
<title>Results</title>
<p>In the independent test cohort, LR achieved the highest performance [accuracy 0.897, AUC 0.929 (95% CI, 0.838&#x2013;1.000), sensitivity 0.786, and specificity 1.000]. LightGBM and MLP also exhibited robust discrimination with AUC values of 0.855 (95% CI, 0.719&#x2013;0.990) and 0.848 (95% CI, 0.705&#x2013;0.991), respectively. Five texture-oriented and four first-order features were retained, underscoring the importance of texture-focused extractors [wavelet and local binary pattern (LBP)].</p>
</sec>
<sec>
<title>Conclusion</title>
<p>CT-derived radiomic signatures combined with machine learning classifiers enable the accurate detection of RP in breast cancer patients. Texture-oriented feature selection enhances model discrimination, providing potential for the personalized diagnosis of RP in breast cancer patients and adaptive treatment planning.</p>
</sec>
</abstract>
<kwd-group>
<kwd>breast cancer</kwd>
<kwd>radiomics</kwd>
<kwd>radiation pneumonitis</kwd>
<kwd>machine learning</kwd>
<kwd>artificial intelligence</kwd>
</kwd-group>
<counts>
<fig-count count="7"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="32"/>
<page-count count="10"/>
<word-count count="3212"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Cancer Imaging and Image-directed Interventions</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The 2020 Global Cancer Statistics found 2.26 million new cases of breast cancer, making it the most common cancer globally, surpassing lung cancer (<xref ref-type="bibr" rid="B1">1</xref>). Radiotherapy has become a critical component in treating breast cancer using high-energy rays to prevent the growth or kill cancer cells, leading to reduced recurrence rate and improved quality of life for patients (<xref ref-type="bibr" rid="B2">2</xref>&#x2013;<xref ref-type="bibr" rid="B9">9</xref>). However, patients may experience different side effects during the radiation treatment due to the tumor&#x2019;s location and anatomical structures. Radiation pneumonitis (RP), a prevalent side effect after radiation therapy for breast cancer, impacts subsequent radiation dosages and treatment strategies and significantly influences patients&#x2019; quality of life and post-treatment recovery. Therefore, the accurate diagnosis and prediction of RP occurrence can help clinical oncologists adjust treatment plans rapidly, thereby improving patients&#x2019; prognosis and quality of life.</p>
<p>Radiomics is a cutting-edge technology that converts region of interest (ROI) image data into high-resolution feature space data that can be easily processed through advanced data characterization algorithms (<xref ref-type="bibr" rid="B10">10</xref>). Through radiomics, valuable information can be extracted from image data in an efficient and automated manner, allowing for accurate diagnoses and prognoses. Therefore, radiomics is promising to provide an approach to address the diagnosis and prognosis of RP.</p>
<p>Currently, some studies have attempted to use radiomics to predict the occurrence and grading of RP (<xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). However, a majority of them have focused on the occurrence of RP after radiotherapy for lung cancer treatment, while fewer studies have been conducted on that after radiotherapy for breast cancer. RP after radiotherapy for lung cancer mainly appears in the lobes of the lung where the primary lesion is present. However, radiation-induced RP for breast cancer is mainly in the first to second intercostal space. This difference in location can impact the extracted radiomic features to some extent, affecting the results obtained from radiomics analysis. Therefore, the present study aimed to investigate radiomic feature changes on CT images before and after radiotherapy in breast cancer patients with RP and to assess the potential of these features for diagnosing RP, thereby facilitating improved prognosis and personalized treatment strategies for breast cancer patients.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Patient population</title>
<p>This study collected a total of 146 samples, consisting of 73 breast cancer patients&#x2019; CT images before and after radiation therapy at a ratio of 1:1. The patients presented at Yunnan Cancer Hospital between September 2019 and March 2023 and were complicated with radiation pneumonitis after radiation therapy. The CT images before radiation therapy were used as negative samples, while the CT images after radiation therapy were used as positive samples. Their ages ranged from 30 to 72 years, with the median age being 48 years, and the majority of patients underwent modified radical mastectomy, while a minority received breast-conserving surgery, with all of the patients having no smoking history. Their TNM clinical stages ranged from I to III, with Stage II and Stage III accounting for the majority. The molecular subtypes were predominantly Luminal A and Luminal B, and all patients received intensity-modulated radiation therapy (IMRT). Patients meeting the following criteria were included in the study: 1) patients who had pathologically confirmed breast cancer, 2) patients whose diagnosis of radiation pneumonitis followed the GBZ110&#x2013;2002 guidelines, 3) patients with complete pre- and post-radiotherapy imaging and clinical data, and 4) patients without severe cardiac or pulmonary disease and other contraindications to radiotherapy. The dataset was randomly divided into a training set (n = 117) and a test set (n = 29) at a ratio of 8:2.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>CT images and ROI acquisition</title>
<p>In this study, a Siemens (Somatom Force) third-generation dual-source CT system was utilized for image scanning of patients with breast cancer with a layer thickness of 1&#x2013;2 mm, a tube voltage of 120 kV, a tube current of 30 mAs, an image size of 512 &#xd7; 512 pixels, and image reconstruction algorithm(s) using Filtered Back Projection. The scanning range included complete and clear lung organs. The ROI was delineated by two clinical oncologists using the 3D slicer 4.11 software (<xref ref-type="bibr" rid="B15">15</xref>) with the whole lung delineated layer by layer, and the required ROI was reviewed and corrected by a senior radiologist (as shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Whole lung (ROI) outlined by physicians. ROI, region of interest.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1609421-g001.tif">
<alt-text content-type="machine-generated">3D rendering and cross-sectional CT scans of human lungs. The left shows a green 3D model of lungs, while the right features three CT images displaying lungs in different orientations with green coloring indicating lung tissue.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Radiomic feature extraction</title>
<p>To eliminate the influence of image voxel size variation as much as possible, the images were resampled to 3 * 3 * 3 mm before extracting features in this study. The Radiomics package (<ext-link ext-link-type="uri" xlink:href="http://pyradiomics.readthedocs.io">http://pyradiomics.readthedocs.io</ext-link>) extracted radiomic features from the ROI (<xref ref-type="bibr" rid="B16">16</xref>). Nine image types were used for feature extraction: original, Laplacian of Gaussian (LoG), wavelet, LBP3D, exponential, square, square root, logarithm, and gradient. The sigma values of LoG were 1, 2, and 3. Wavelet included eight filters: wavelet-LLH, wavelet-LHL, wavelet-LHH, wavelet-HLL, wavelet-HLH, wavelet-HHL, wavelet-HHH, and wavelet-LLL. A total of 1,834 radiomic features were obtained, including 14 shape features (shape), 360 first-order features, 440 gray-level co-occurrence matrix (GLCM) features, 280 gray-level dependence matrix (GLDM) features, 320 gray-level run length matrix (GLRLM) features, 320 gray-level size zone matrix (GLSZM) features, and 100 neighboring gray tone difference matrix (NGTDM) features, as shown in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>. The details of the features can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary File S1</bold>
</xref>.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Number and ratio of handcrafted features, among which first-order stands for first-order features, shape for shape features, glcm for gray-level co-occurrence matrix features, glszm for gray-level size zone matrix features, glrlm for gray-level run length matrix features, ngtdm for neighboring gray tone difference matrix features, and gldm for gray-level dependence matrix features.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1609421-g002.tif">
<alt-text content-type="machine-generated">A pie chart with six segments labeled: glrm (17.4%), glszm (17.4%), gldm (15.3%), ngtdm (5.5%), shape (0.8%), and firstorder (19.6%). The largest segment is glcm at 24%.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Feature selection</title>
<p>We used Z-score to standardize the extracted features and performed data screening in three ways:
statistical analysis, correlation analysis, and least absolute shrinkage and selection operator (LASSO) on the standardized data. First, we used the Mann&#x2013;Whitney U-test statistical test for radiomic feature selection and retained 328 radiomic features with the p-value &lt; 0.05. Second, we performed Spearman&#x2019;s rank correlation analysis on the 328 radiomic features to eliminate redundant features with high repeatability, as shown in <xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Material Figure&#xa0;1</bold>
</xref>, and retained one of the&#xa0;two features with a correlation coefficient greater than 0.9, yielding a total of 82 features. Finally, we constructed the 82 obtained features using the LASSO model, which compressed the coefficients of the features by adjusting the weights &#x3bb; and changed the coefficients of some of the features to zero to achieve feature selection. Our study performed a 10-fold cross-validation to find the optimal values, as shown in <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3</bold>
</xref> and <xref ref-type="fig" rid="f4">
<bold>4</bold>
</xref>, and we retained the features with non-zero coefficients for fitting the regression model and combined them into a radiomic signature. The optimal value of &#x3bb; in this study was 0.0391.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Relationship between lambda and regression coefficients (the optimal value of lambda is 0.0391).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1609421-g003.tif">
<alt-text content-type="machine-generated">Line graph displaying multiple coefficient paths against lambda values on a logarithmic scale. Coefficients are on the y-axis ranging from negative one point five to two, and lambda on the x-axis from ten to the power of negative three to ten. Lines converge towards zero as lambda increases, with a vertical dashed line indicating lambda equals zero point zero three nine one.</alt-text>
</graphic>
</fig>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>The MSE of LASSO regression.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1609421-g004.tif">
<alt-text content-type="machine-generated">Plot showing the relationship between Lambda and Mean Squared Error (MSE). The x-axis is labeled with Lambda values ranging from 10^-3 to 10^0. The y-axis indicates MSE values from 0.1 to 0.7. Red dots represent data points, and blue vertical lines indicate error bars. A dashed line marks the optimal Lambda value at 0.0391 where MSE is minimized.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Model construction and evaluation metrics</title>
<p>Our study utilized the sklearn package in Python 3 to build machine learning models. Specifically, we applied eight different algorithms: logistic regression (LR), support vector machine (SVM), K-nearest neighbors (KNN), random forest (RF), Extra Tree (ET), XGBoost, LightGBM, and multilayer perceptron (MLP). All of them were employed to discriminate RP, using four different metrics&#x2014;accuracy, the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity&#x2014;and ROC curves to further assess their effectiveness.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Radiomic feature filtering</title>
<p>In this study, the 1,834 features extracted from the ROI were filtered through several steps, with nine retained radiomic features for the training and testing of the machine learning models, including four first-order features, two GLSZM features, and three GLCM features, as shown in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. In order to show the weight of each feature more visually, the weight histogram and Rad score of the nine features were plotted, as shown in <xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5</bold>
</xref> and <xref ref-type="fig" rid="f6">
<bold>6</bold>
</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Radiomic features obtained after LASSO dimensionality reduction.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Feature type</th>
<th valign="top" align="left">Features</th>
<th valign="top" align="left">Feature weights</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">exponential_firstorder</td>
<td valign="top" align="left">RobustMeanAbsoluteDeviation</td>
<td valign="top" align="left">0.005837</td>
</tr>
<tr>
<td valign="top" align="left">exponential_glszm</td>
<td valign="top" align="left">ZonePercentage</td>
<td valign="top" align="left">0.053475</td>
</tr>
<tr>
<td valign="top" align="left">lbp_3D_m1_glcm</td>
<td valign="top" align="left">Imc2</td>
<td valign="top" align="left">&#x2212;0.161096</td>
</tr>
<tr>
<td valign="top" align="left">lbp_3D_m1_glszm</td>
<td valign="top" align="left">ZoneVariance</td>
<td valign="top" align="left">&#x2212;0.022473</td>
</tr>
<tr>
<td valign="top" align="left">logarithm_firstorder</td>
<td valign="top" align="left">RobustMeanAbsoluteDeviation</td>
<td valign="top" align="left">0.014765</td>
</tr>
<tr>
<td valign="top" align="left">logarithm_glcm</td>
<td valign="middle" align="left">SumEntropy</td>
<td valign="middle" align="left">0.014366</td>
</tr>
<tr>
<td valign="top" align="left">squareroot_firstorder</td>
<td valign="middle" align="left">90Percentile</td>
<td valign="middle" align="left">0.052493</td>
</tr>
<tr>
<td valign="top" align="left">wavelet_LHH_firstorder</td>
<td valign="middle" align="left">Mean</td>
<td valign="middle" align="left">0.119742</td>
</tr>
<tr>
<td valign="top" align="left">wavelet_LHH_glcm</td>
<td valign="top" align="left">Correlation</td>
<td valign="middle" align="left">&#x2212;0.005163</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>LASSO, least absolute shrinkage and selection operator.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Weights of the nine radiomic features.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1609421-g005.tif">
<alt-text content-type="machine-generated">Bar chart showing coefficients for various features in a model. The most significant positive coefficient is for &#x201c;wavelet_LHH_firstorder_Mean,&#x201d; while &#x201c;lbp_3D_m1_glcm_lmc2&#x201d; has a large negative coefficient. Other features include &#x201c;exponential_glszm_ZonePercentage&#x201d; and &#x201c;squareroot_firstorder_90Percentile."</alt-text>
</graphic>
</fig>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Graph of Rad-score results.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1609421-g006.tif">
<alt-text content-type="machine-generated">Mathematical formula with variables and coefficients related to an equation involving exponential, logarithm, and wavelet functions, including terms like &#x201c;glcm_Imc2&#x201d;, &#x201c;ZonePercentage&#x201d;, and &#x201c;SumEntropy&#x201d;.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Radiomics model prediction</title>
<p>We developed eight machine learning models to predict radiation pneumonitis based on selected radiomic features, as shown in <xref ref-type="table" rid="T2"><bold>Table 2</bold></xref>. The SVM model demonstrated the highest accuracy on the test set, while the LR model achieved the best overall predictive performance, indicated by the highest AUC and specificity. Most of the models, except the ET model, showed robust diagnostic potential with AUC scores exceeding 0.7, confirming that radiomics-based machine learning can effectively identify radiation pneumonitis in breast cancer patients. ROC curves for these models further illustrate their comparative performances (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>ROC analysis of different models on Rad signature. ROC, receiver operating characteristic.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-15-1609421-g007.tif">
<alt-text content-type="machine-generated">ROC curve comparing the performance of various models. Logistic Regression has the highest AUC of 0.929, followed by LightGBM with 0.855. XGBoost, KNN, and SVM show moderate performances. ExtraTrees has the lowest AUC of 0.600. A diagonal line represents random chance.</alt-text>
</graphic>
</fig>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Predictive performance of eight models in the training cohort and test cohort.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="left">Model</th>
<th valign="middle" colspan="4" align="left">Training cohort (n = 116)</th>
<th valign="middle" colspan="4" align="left">Testing cohort (n = 29)</th>
</tr>
<tr>
<th valign="middle" align="left">Accuracy</th>
<th valign="middle" align="left">AUC (95% CI)</th>
<th valign="middle" align="left">Sensitivity</th>
<th valign="middle" align="left">Specificity</th>
<th valign="middle" align="left">Accuracy</th>
<th valign="middle" align="left">AUC (95% CI)</th>
<th valign="middle" align="left">Sensitivity</th>
<th valign="middle" align="left">Specificity</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">LR</td>
<td valign="top" align="left">0.761</td>
<td valign="top" align="left">0.83 (0.756&#x2013;0.903)</td>
<td valign="top" align="left">0.542</td>
<td valign="top" align="left">0.983</td>
<td valign="top" align="left">0.897</td>
<td valign="top" align="left">0.929 (0.8383-1.000)</td>
<td valign="top" align="left">0.786</td>
<td valign="top" align="left">1</td>
</tr>
<tr>
<td valign="top" align="left">SVM</td>
<td valign="top" align="left">0.812</td>
<td valign="top" align="left">0.901 (0.849&#x2013;0.952)</td>
<td valign="top" align="left">0.712</td>
<td valign="top" align="left">0.914</td>
<td valign="top" align="left">0.901</td>
<td valign="top" align="left">0.805 (0.645&#x2013;0.965)</td>
<td valign="top" align="left">0.643</td>
<td valign="top" align="left">0.867</td>
</tr>
<tr>
<td valign="top" align="left">KNN</td>
<td valign="top" align="left">0.786</td>
<td valign="top" align="left">0.852 (0.787&#x2013;0.916)</td>
<td valign="top" align="left">0.678</td>
<td valign="top" align="left">0.897</td>
<td valign="top" align="left">0.724</td>
<td valign="top" align="left">0.793 (0.625&#x2013;0.961)</td>
<td valign="top" align="left">0.786</td>
<td valign="top" align="left">0.667</td>
</tr>
<tr>
<td valign="top" align="left">Random forest</td>
<td valign="top" align="left">0.983</td>
<td valign="top" align="left">0.999 (0.997&#x2013;1.000)</td>
<td valign="top" align="left">0.966</td>
<td valign="top" align="left">1</td>
<td valign="top" align="left">0.724</td>
<td valign="top" align="left">0.688 (0.483&#x2013;0.893)</td>
<td valign="top" align="left">0.571</td>
<td valign="top" align="left">0.867</td>
</tr>
<tr>
<td valign="top" align="left">Extra Tree</td>
<td valign="top" align="left">1</td>
<td valign="top" align="left">1 (1.000&#x2013;1.000)</td>
<td valign="top" align="left">1</td>
<td valign="top" align="left">1</td>
<td valign="top" align="left">0.621</td>
<td valign="top" align="left">0.6 (0.384&#x2013;0.816)</td>
<td valign="top" align="left">0.571</td>
<td valign="top" align="left">0.667</td>
</tr>
<tr>
<td valign="top" align="left">XGBoost</td>
<td valign="top" align="left">1</td>
<td valign="top" align="left">1 (1.000&#x2013;1.000)</td>
<td valign="top" align="left">1</td>
<td valign="top" align="left">1</td>
<td valign="top" align="left">0.793</td>
<td valign="top" align="left">0.733 (0.534&#x2013;0.932)</td>
<td valign="top" align="left">0.571</td>
<td valign="top" align="left">1</td>
</tr>
<tr>
<td valign="top" align="left">LightGBM</td>
<td valign="top" align="left">0.872</td>
<td valign="top" align="left">0.942 (0.904&#x2013;0.980)</td>
<td valign="top" align="left">0.881</td>
<td valign="top" align="left">0.862</td>
<td valign="top" align="left">0.793</td>
<td valign="top" align="left">0.855 (0.719&#x2013;0.990)</td>
<td valign="top" align="left">0.571</td>
<td valign="top" align="left">1</td>
</tr>
<tr>
<td valign="top" align="left">MLP</td>
<td valign="top" align="left">0.778</td>
<td valign="top" align="left">0.818 (0.741&#x2013;0.894)</td>
<td valign="top" align="left">0.797</td>
<td valign="top" align="left">0.759</td>
<td valign="top" align="left">0.828</td>
<td valign="top" align="left">0.848 (0.705&#x2013;0.991)</td>
<td valign="top" align="left">0.786</td>
<td valign="top" align="left">0.867</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>SVM, support vector machine; KNN, K-nearest neighbor; MLP, multilayer perceptron; AUC, area under the receiver operating characteristic curve.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussions</title>
<p>Previous studies on RP have mainly focused on its prediction and diagnosis using dosimetric parameters, pulmonary metabolic activity, etc. (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). However, this predictive approach&#x2019;s precision and robustness still need to be improved. With the development of artificial intelligence, radiomics provides a novel approach for diagnosis and prognosis in clinical practice.</p>
<p>Numerous studies have confirmed that radiomics-based models exhibit robust and superior performance across multiple cancer-related prediction and classification tasks (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Therefore, radiomics can non-invasively extract imaging information and analyze its potential clinical value in a high-throughput manner to establish a practical model for prognosis and discrimination in clinical applications, thus potentially enabling the development of non-invasive differential models for the diagnosis of RP (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>Current studies have demonstrated that the integration of radiomic features with machine learning algorithms substantially improves predictive accuracy for RP differentiation in radiotherapy settings, thereby establishing a foundation for developing clinically applicable RP diagnostic models (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). However, most of these radiomics studies focused on lung cancer, where the tumors&#x2019; anatomical location and adjacent structures may present radiomic feature alterations in the lung, affecting the prediction results and the validity of the extracted features for radiolucency after radiotherapy for lung cancer. RP after the radiotherapy for breast cancer is mainly in the first to second intercostal space, and the lung is less affected by the tumor. Consequently, the generalizability and robustness of the extracted features based on lung cancer may be affected to different degrees. Therefore, there is a need to personalize the diagnosis and prognosis of RP for breast cancer patients.</p>
<p>Our study aimed to detect radiomics changes on CT images before and after radiotherapy and explore the feasibility of employing them to discriminate the occurrence of RP in patients with breast cancer after radiotherapy. We utilized various machine learning models to diagnose the occurrence of RP after radiotherapy. It is noteworthy that we initially personalize the diagnosis of RP by comparing radiomics changes on CT images before and after radiation therapy in breast cancer patients who develop RP.</p>
<p>Currently, the investigators&#x2019; selection of deep learning models or classification algorithms in their study is usually determined by their experience, or they consider factors such as the frequency of being cited in the literature, data characteristics and quality, and the availability of simple implementation (<xref ref-type="bibr" rid="B23">23</xref>). Parmar et&#xa0;al. (<xref ref-type="bibr" rid="B24">24</xref>) found that the choice of different classification methods had a significant impact on the model performance (34.21% of the total variance of the models). Therefore, the appropriate choice of machine learning model is crucial for the prediction. In this study, eight machine learning models were constructed for prediction, and the results showed that, except for the Extra Tree model, the seven other machine learning models presented AUC values higher than 0.7 in the test cohort. The LR model was optimal for AUC, sensitivity, and specificity metrics in the test set, with an AUC value of 0.929, which indicated that the radiomic features obtained from CT images could effectively individualize the diagnosis of RP in breast cancer patients. It can assist clinical oncologists in rapid diagnosis and the adjustment of treatment plans. A total of nine radiomic features were selected in this study, including five textural features, which may be explained by the fact that lung texture is altered to varying degrees in the presence of RP, which is consistent with the assumption that textural features are more suitable for detecting tissue structural heterogeneity on imaging (<xref ref-type="bibr" rid="B25">25</xref>). Mean, 90Percentile, and RobustMeanAbsoluteDeviation were selected as the first-order features, probably because of the significant grayscale changes in the lungs in the presence of RP, which may lead to changes in the mean grayscale values and 90Percentile and RobustMeanAbsoluteDeviation. Cunliffe et&#xa0;al. (<xref ref-type="bibr" rid="B26">26</xref>) explored the correlation of radiomic features with radiotherapy dose and the occurrence of RP based on CT images of patients undergoing radiotherapy for lung cancer. Similarly, they found that there was a statistically significant relationship between MEAN features in first-order features and the occurrence of RP (p &lt; 0.0025), which is similar to the results of the present study. It is worth noting that most of the radiomic features extracted in this study were features obtained by the wavelet extractor and local binary pattern (LBP) extractor, and the wavelet transform can extract features from the frequency domain and effectively enhance the texture features of CT. Also, LBP is an operator used to describe local texture features of images. Jiang et&#xa0;al. (<xref ref-type="bibr" rid="B27">27</xref>) used a CT-based wavelet transform radiomics method to grade lung lesions caused by COVID-19, and the results showed that wavelet transform could enhance CT texture features, and wavelet transform radiomics based on CT images can be used to assess the grading of COVID-19-induced lung lesions effectively. Additionally, similar findings have proved that all radiomic features with wavelet filters that were selected using LASSO regression were important predictors for the prediction of RP grade (<xref ref-type="bibr" rid="B21">21</xref>). Therefore, combined with the results of this study, it can be inferred that texture features are an important component for the diagnosis of RP in breast cancer patients and that feature extractors such as LBP and wavelet that can enhance or amplify texture features may be more advantageous, and it is recommended that extractors that can focus on texture features should be added when performing radiomic feature extraction for RP in breast cancer.</p>
<p>There is still some room for improvement in this study. This study only used radiomic features for diagnosing RP. In future studies, it is necessary to consider the influence of patients&#x2019; clinical traits, such as age, gender, smoking status, and lung disease (<xref ref-type="bibr" rid="B28">28</xref>). Dose parameters during treatment planning can affect the incidence rate of RP and should also be used as a reference (<xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>).</p>
<p>Furthermore, future research should implement clinical stage stratification to identify stage-specific radiomic signature alterations. Other approaches, such as visual assessment systems (e.g., radiological scoring scales), should be incorporated to augment the feature pool. Also, this study is a single-center study with limited samples, and the models&#x2019; robustness and generalization will be somewhat challenged; additional datasets and multi-center studies should be conducted in the future.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusions</title>
<p>When RP occurs, radiomics is more likely to exhibit changes in texture features and first-order characteristics, and feature extractors that can focus on or amplify texture features, such as wavelets and LBP, may be more advantageous in discriminating the RP occurrence. Meanwhile, machine learning models based on radiomic features can effectively predict the RP occurrence.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>This study was approved by the Ethics Committee of Yunnan Cancer Hospital (KYLX2022187). Given that this is a retrospective study and all images involved in the study have been processed  to eliminate any identifiable subject information,  the Ethics Committee approved a waiver of informed consent for this research.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>XW: Software, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. YZ: Data curation, Investigation, Writing &#x2013; original draft. WD: Data curation, Writing &#x2013; original draft. CY: Data curation, Writing &#x2013; original draft. JL: Data curation, Writing &#x2013; original draft. LS: Data curation, Writing &#x2013; original draft. YX: Data curation, Writing &#x2013; original draft. CG: Methodology, Supervision, Writing &#x2013; review &amp; editing. MZ: Data curation, Funding acquisition, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by the National Natural Science Foundation of China (grant number 81860537), Yunnan provincial health commission medical discipline leader training project (grant number D-2019031), and Reserve Talents of Young and Middle-aged Academic and Technological Leaders Plan of Yunnan Provincial Department of Science and Technology (grant number 202105AC160026).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We are thankful for the data support provided by Yunnan Cancer Hospital.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="correction-statement">
<title>Correction note</title>
<p>A correction has been made to this article. Details can be found at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fonc.2025.1674168">10.3389/fonc.2025.1674168</ext-link>.</p>
</sec>
<sec id="s12" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s13" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s14" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fonc.2025.1609421/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fonc.2025.1609421/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.zip" id="SM1" mimetype="application/zip">
<label>Supplementary File S1</label>
<caption>
<p>Radiomics features.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="DataSheet1.zip" id="SF1" mimetype="application/zip">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>Cluster analysis of radiomics features (Darker colors represent more positive correlations between features, and lighter colors represent more negative correlations).</p>
</caption>
</supplementary-material>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr" id="abbrev1">
<p>AUC, area under the curve; ET, Extra Tree; GLCM, gray-level co-occurrence matrix; GLDM, gray-level dependence matrix; GLRLM, gray-level run length matrix; GLSZM, gray-level size zone matrix; KNN, K-nearest neighbors; LASSO, least absolute shrinkage and selection operator; LBP, local binary pattern; LoG, Laplacian of Gaussian; LR, logistic regression; MLP, multilayer perceptron; ROC, receiver operating characteristic; ROI, region of interest; RP, radiation pneumonitis; SVM, support vector machine.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ferlay</surname> <given-names>J</given-names>
</name>
<name>
<surname>Siegel</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Laversanne</surname> <given-names>M</given-names>
</name>
<name>
<surname>Soerjomataram</surname> <given-names>I</given-names>
</name>
<name>
<surname>Jemal</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J Clin</source>. (<year>2021</year>) <volume>71</volume>:<page-range>209&#x2013;49</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21660</pub-id>, PMID: <pub-id pub-id-type="pmid">33538338</pub-id></citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Survival comparison between postoperative and preoperative radiotherapy for stage I-iii non-inflammatory breast cancer</article-title>. <source>Sci Rep</source>. (<year>2022</year>) <volume>12</volume>:<fpage>14288</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-022-18251-3</pub-id>, PMID: <pub-id pub-id-type="pmid">35995985</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernier</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Post-mastectomy radiotherapy after neodjuvant chemotherapy in breast cancer patients: A review</article-title>. <source>Crit Rev Oncol Hematol</source>. (<year>2015</year>) <volume>93</volume>:<page-range>180&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.critrevonc.2014.10.011</pub-id>, PMID: <pub-id pub-id-type="pmid">25465740</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Trends and outcomes of neoadjuvant radiotherapy compared with postoperative radiotherapy for Malignant breast cancer</article-title>. <source>Oncotarget</source>. (<year>2018</year>) <volume>9</volume>:<page-range>24525&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/oncotarget.24313</pub-id>, PMID: <pub-id pub-id-type="pmid">29849958</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cassidy</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kahn</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Jegadeesh</surname> <given-names>NK</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Subhedar</surname> <given-names>PD</given-names>
</name>
<etal/>
</person-group>. <article-title>The role of postmastectomy radiotherapy in women with pathologic T3n0m0 breast cancer</article-title>. <source>Cancer</source>. (<year>2017</year>) <volume>123</volume>:<page-range>2829&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cncr.30675</pub-id>, PMID: <pub-id pub-id-type="pmid">28387923</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>OH</surname> <given-names>N</given-names>
</name>
<name>
<surname>McVeigh</surname> <given-names>T</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Keane</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lowery</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kerin</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Neoadjuvant chemoradiation and breast reconstruction: the potential for improved outcomes in the treatment of breast cancer</article-title>. <source>Ir J Med Sci</source>. (<year>2019</year>) <volume>188</volume>:<fpage>75</fpage>&#x2013;<lpage>83</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11845-018-1846-6</pub-id>, PMID: <pub-id pub-id-type="pmid">29948462</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandilaras</surname> <given-names>V</given-names>
</name>
<name>
<surname>Bouganim</surname> <given-names>N</given-names>
</name>
<name>
<surname>Spayne</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dent</surname> <given-names>R</given-names>
</name>
<name>
<surname>Arnaout</surname> <given-names>A</given-names>
</name>
<name>
<surname>Boileau</surname> <given-names>JF</given-names>
</name>
<etal/>
</person-group>. <article-title>Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm</article-title>? <source>Curr Oncol</source>. (<year>2015</year>) <volume>22</volume>:<fpage>25</fpage>&#x2013;<lpage>32</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3747/co.21.2043</pub-id>, PMID: <pub-id pub-id-type="pmid">25684986</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaughnessy</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Meena</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Dunlap</surname> <given-names>NE</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>D</given-names>
</name>
<name>
<surname>Riley</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Quillo</surname> <given-names>AR</given-names>
</name>
<etal/>
</person-group>. <article-title>Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancer</article-title>. <source>Clin Breast Cancer</source>. (<year>2015</year>) <volume>15</volume>:<page-range>135&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clbc.2014.10.007</pub-id>, PMID: <pub-id pub-id-type="pmid">25454741</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iyer</surname> <given-names>P</given-names>
</name>
<name>
<surname>Radhakrishnan</surname> <given-names>V</given-names>
</name>
<name>
<surname>Balasubramanian</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sridevi</surname> <given-names>V</given-names>
</name>
<name>
<surname>Krishnamurthy</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dhanushkodi</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Study of pathological complete response rate with neoadjuvant concurrent chemoradiation with paclitaxel in locally advanced breast cancer</article-title>. <source>Indian J Cancer</source>. (<year>2020</year>) <volume>57</volume>:<page-range>428&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/ijc.IJC_524_19</pub-id>, PMID: <pub-id pub-id-type="pmid">32675440</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambin</surname> <given-names>P</given-names>
</name>
<name>
<surname>Rios-Velazquez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Leijenaar</surname> <given-names>R</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>S</given-names>
</name>
<name>
<surname>van Stiphout</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Granton</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Radiomics: extracting more information from medical images using advanced feature analysis</article-title>. <source>Eur J Cancer</source>. (<year>2012</year>) <volume>48</volume>:<page-range>441&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejca.2011.11.036</pub-id>, PMID: <pub-id pub-id-type="pmid">22257792</pub-id></citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krafft</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Rao</surname> <given-names>A</given-names>
</name>
<name>
<surname>Stingo</surname> <given-names>F</given-names>
</name>
<name>
<surname>Briere</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Court</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>The utility of quantitative ct radiomics features for improved prediction of radiation pneumonitis</article-title>. <source>Med Phys</source>. (<year>2018</year>) <volume>45</volume>:<page-range>5317&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mp.13150</pub-id>, PMID: <pub-id pub-id-type="pmid">30133809</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dekker</surname> <given-names>A</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Radiomics and dosiomics signature from whole lung predicts radiation pneumonitis: A model development study with prospective external validation and decision-curve analysis</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. (<year>2022</year>) <volume>115</volume>:<page-range>746&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijrobp.2022.08.047</pub-id>, PMID: <pub-id pub-id-type="pmid">36031028</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname> <given-names>F</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel nomogram model based on cone-beam ct radiomics analysis technology for predicting radiation pneumonitis in esophageal cancer patients undergoing radiotherapy</article-title>. <source>Front Oncol</source>. (<year>2020</year>) <volume>10</volume>:<elocation-id>596013</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2020.596013</pub-id>, PMID: <pub-id pub-id-type="pmid">33392091</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Development and validation of a radiomics nomogram using computed tomography for differentiating immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis for patients with non-small cell lung cancer</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>870842</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.870842</pub-id>, PMID: <pub-id pub-id-type="pmid">35558076</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fedorov</surname> <given-names>A</given-names>
</name>
<name>
<surname>Beichel</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kalpathy-Cramer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Finet</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fillion-Robin</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Pujol</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>3d slicer as an image computing platform for the quantitative imaging network</article-title>. <source>Magn Reson Imaging</source>. (<year>2012</year>) <volume>30</volume>:<page-range>1323&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mri.2012.05.001</pub-id>, PMID: <pub-id pub-id-type="pmid">22770690</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Griethuysen</surname> <given-names>JJM</given-names>
</name>
<name>
<surname>Fedorov</surname> <given-names>A</given-names>
</name>
<name>
<surname>Parmar</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hosny</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aucoin</surname> <given-names>N</given-names>
</name>
<name>
<surname>Narayan</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Computational radiomics system to decode the radiographic phenotype</article-title>. <source>Cancer Res</source>. (<year>2017</year>) <volume>77</volume>:<page-range>e104&#x2013;e7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/0008-5472.Can-17-0339</pub-id>, PMID: <pub-id pub-id-type="pmid">29092951</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giridhar</surname> <given-names>P</given-names>
</name>
<name>
<surname>Mallick</surname> <given-names>S</given-names>
</name>
<name>
<surname>Rath</surname> <given-names>GK</given-names>
</name>
<name>
<surname>Julka</surname> <given-names>PK</given-names>
</name>
</person-group>. <article-title>Radiation induced lung injury: prediction, assessment and management</article-title>. <source>Asian Pac J Cancer Prev</source>. (<year>2015</year>) <volume>16</volume>:<page-range>2613&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7314/apjcp.2015.16.7.2613</pub-id>, PMID: <pub-id pub-id-type="pmid">25854336</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Ao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lawrence</surname> <given-names>TS</given-names>
</name>
</person-group>. <article-title>The use of blood biomarkers to predict radiation lung toxicity: A potential strategy to individualize thoracic radiation therapy</article-title>. <source>Cancer Control</source>. (<year>2008</year>) <volume>15</volume>:<page-range>140&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/107327480801500206</pub-id>, PMID: <pub-id pub-id-type="pmid">18376381</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Ultrasound-based radiomics analysis for predicting disease-free survival of invasive breast cancer</article-title>. <source>Front Oncol</source>. (<year>2021</year>) <volume>11</volume>:<elocation-id>621993</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2021.621993</pub-id>, PMID: <pub-id pub-id-type="pmid">33996546</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>D</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Ct-based radiomics analysis of different machine learning models for differentiating benign and Malignant parotid tumors</article-title>. <source>Eur Radiol</source>. (<year>2022</year>) <volume>32</volume>:<page-range>6953&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00330-022-08830-3</pub-id>, PMID: <pub-id pub-id-type="pmid">35484339</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawahara</surname> <given-names>D</given-names>
</name>
<name>
<surname>Imano</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nishioka</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ogawa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kimura</surname> <given-names>T</given-names>
</name>
<name>
<surname>Nakashima</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis</article-title>. <source>Sci Rep</source>. (<year>2021</year>) <volume>11</volume>:<fpage>16232</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-95643-x</pub-id>, PMID: <pub-id pub-id-type="pmid">34376721</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>W</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>C</given-names>
</name>
<name>
<surname>Han</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Radiomics-based hybrid model for predicting radiation pneumonitis: A systematic review and meta-analysis</article-title>. <source>Physica Med</source>. (<year>2024</year>) <volume>123</volume>:<elocation-id>103414</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejmp.2024.103414</pub-id>, PMID: <pub-id pub-id-type="pmid">38906047</pub-id></citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deist</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Dankers</surname> <given-names>FJWM</given-names>
</name>
<name>
<surname>Valdes</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wijsman</surname> <given-names>R</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>I-C</given-names>
</name>
<name>
<surname>Oberije</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Machine learning algorithms for outcome prediction in (Chemo)Radiotherapy: an empirical comparison of classifiers</article-title>. <source>Medical physics</source> (<year>2018</year>) <volume>45</volume>:<page-range>3449&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mp.12967</pub-id>, PMID: <pub-id pub-id-type="pmid">29763967</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parmar</surname> <given-names>C</given-names>
</name>
<name>
<surname>Grossmann</surname> <given-names>P</given-names>
</name>
<name>
<surname>Bussink</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lambin</surname> <given-names>P</given-names>
</name>
<name>
<surname>Aerts</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Machine learning methods for quantitative radiomic biomarkers</article-title>. <source>Sci Rep</source>. (<year>2015</year>) <volume>5</volume>:<elocation-id>13087</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep13087</pub-id>, PMID: <pub-id pub-id-type="pmid">26278466</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasanna</surname> <given-names>P</given-names>
</name>
<name>
<surname>Tiwari</surname> <given-names>P</given-names>
</name>
<name>
<surname>Madabhushi</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Co-occurrence of local anisotropic gradient orientations (Collage): A new radiomics descriptor</article-title>. <source>Sci Rep</source>. (<year>2016</year>) <volume>6</volume>:<elocation-id>37241</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep37241</pub-id>, PMID: <pub-id pub-id-type="pmid">27872484</pub-id></citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunliffe</surname> <given-names>A</given-names>
</name>
<name>
<surname>Armato</surname> <given-names>SG</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Castillo</surname> <given-names>R</given-names>
</name>
<name>
<surname>Pham</surname> <given-names>N</given-names>
</name>
<name>
<surname>Guerrero</surname> <given-names>T</given-names>
</name>
<name>
<surname>Al-Hallaq</surname> <given-names>HA</given-names>
</name>
</person-group>. <article-title>Lung&#xa0;texture in serial thoracic computed tomography scans: correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. (<year>2015</year>) <volume>91</volume>:<page-range>1048&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijrobp.2014.11.030</pub-id>, PMID: <pub-id pub-id-type="pmid">25670540</pub-id></citation></ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Han</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Wavelet transformation can enhance computed tomography texture features: A multicenter radiomics study for grade assessment of covid-19 pulmonary lesions</article-title>. <source>Quant Imaging Med Surg</source>. (<year>2022</year>) <volume>12</volume>:<page-range>4758&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/qims-22-252</pub-id>, PMID: <pub-id pub-id-type="pmid">36185061</pub-id></citation></ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogelius</surname> <given-names>IR</given-names>
</name>
<name>
<surname>Bentzen</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis</article-title>. <source>Acta Oncol</source>. (<year>2012</year>) <volume>51</volume>:<page-range>975&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/0284186x.2012.718093</pub-id>, PMID: <pub-id pub-id-type="pmid">22950387</pub-id></citation></ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tucker</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Dinh</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bian</surname> <given-names>SX</given-names>
</name>
<name>
<surname>Mohan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Martel</surname> <given-names>MK</given-names>
</name>
<etal/>
</person-group>. <article-title>Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort</article-title>. <source>Acta Oncol</source>. (<year>2014</year>) <volume>53</volume>:<page-range>590&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/0284186X.2013.831185</pub-id>, PMID: <pub-id pub-id-type="pmid">23992110</pub-id></citation></ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Go</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kasai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yokomise</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shibata</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Relationship between Dose-Volume Parameters and Pulmonary Complications after Neoadjuvant Chemoradiotherapy Followed By surgery for Lung Cancer</article-title>. <source>Strahlenther Onkol</source>. (<year>2016</year>) <volume>192</volume>:<page-range>658&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00066-016-1021-9</pub-id>, PMID: <pub-id pub-id-type="pmid">27418130</pub-id></citation></ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katsui</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ogata</surname> <given-names>T</given-names>
</name>
<name>
<surname>Watanabe</surname> <given-names>K</given-names>
</name>
<name>
<surname>Katayama</surname> <given-names>N</given-names>
</name>
<name>
<surname>Soh</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kuroda</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: A retrospective analysis</article-title>. <source>BMC Cancer</source>. (<year>2019</year>) <volume>19</volume>:<fpage>1144</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12885-019-6359-9</pub-id>, PMID: <pub-id pub-id-type="pmid">31771538</pub-id></citation></ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albain</surname> <given-names>KS</given-names>
</name>
<name>
<surname>Swann</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Rusch</surname> <given-names>VW</given-names>
</name>
<name>
<surname>Turrisi</surname> <given-names>AT</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Shepherd</surname> <given-names>FA</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>.&#xa0;<article-title>Radiotherapy plus chemotherapy with or without surgical resection for stage iii non-small-cell lung cancer: A phase iii randomised controlled trial</article-title>. <source>Lancet</source>. (<year>2009</year>) <volume>374</volume>:<page-range>379&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0140-6736(09)60737-6</pub-id>, PMID: <pub-id pub-id-type="pmid">19632716</pub-id></citation></ref>
</ref-list>
</back>
</article>